Market Tracker

12/22 4:02pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.84
Data as of 11:02am ET
 +0.05 / +2.79%
Today’s Change
0.97
Today|||52-Week Range
2.12
-11.11%
Year-to-Date

Today’s Trading

Previous close1.79
Today’s open1.77
Day’s range1.72 - 1.87
Volume464,547
Average volume (3 months)1,145,799
Market cap$269.8M
Dividend yield--
Data as of 11:02am ET, 12/22/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+27.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.01+0.11%
SVASinovac Biotech Ltd+0.08+1.76%
POZNPOZEN Inc-0.37-4.53%
ECYTEndocyte Inc-0.20-3.21%
Data as of 11:18am ET, 12/22/2014

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Ricardo J. Gonzalez
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts